One study suggested that GDF-15 overexpression promotes fatty acid β-oxidation gene expression while suppressing fibrosis-related gene expression, thereby improving NASH [40]. The gene discussed is GDF15; the disease is metabolic dysfunction-associated steatohepatitis.